Acacia Research Corporation (ACTG)

Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	316.72	273.88	340.09	287.79	308.94	165.55
Short-Term Investments	58.22	59.89	99.82	98.36	398.53	285.79
Cash & Short-Term Investments	374.94	333.77	439.91	386.14	707.47	451.33
Cash Growth	-15.16%	-24.13%	13.92%	-45.42%	56.75%	165.74%
Receivables	23.37	26.91	80.56	8.23	9.52	0.51
Inventory	25.72	27.49	10.92	14.22	8.93	-
Prepaid Expenses	19.96	31.99	23.13	19.39	4.76	5.83
Total Current Assets	443.99	420.15	554.51	427.99	730.68	457.67
Property, Plant & Equipment	220.24	224.83	29.35	5.54	6.21	1.22
Goodwill	25.78	29.34	8.99	7.54	7.47	-
Other Intangible Assets	61.64	55.43	33.56	36.66	48.79	16.91
Long-Term Deferred Tax Assets	17	20.23	2.92	-	-	-
Other Long-Term Assets	6.89	6.42	4.23	1.3	5.7	35.51
Total Assets	775.55	756.39	633.55	482.93	798.86	511.31
Accounts Payable	10.97	12.07	3.26	6.04	5.44	1.02
Accrued Expenses	34.75	24.85	17.5	8.43	7.86	7.55
Short-Term Debt	-	-	-	60.45	181.25	115.66
Current Portion of Leases	-	3.56	1.25	1.56	0.94	0.59
Current Income Taxes Payable	-	3.83	0.62	0.47	0.51	-
Current Unearned Revenue	0.73	1.32	0.98	1.23	1.11	-
Other Current Liabilities	1.59	1.61	4.03	9.04	3.08	-
Total Current Liabilities	50.44	47.24	27.64	87.21	200.19	124.82
Long-Term Debt	101.98	113.99	10.53	-	-	-
Long-Term Leases	7.55	6.78	1.74	1.87	2.03	0.95
Long-Term Unearned Revenue	-	-	-	0.57	0.58	-
Long-Term Deferred Tax Liabilities	2.7	2.61	-	0.74	18.55	-
Other Long-Term Liabilities	35.4	33.16	4.04	86.46	113.83	59.57
Total Liabilities	198.08	203.78	43.94	176.85	335.18	185.34
Common Stock	0.1	0.1	0.1	0.04	0.05	0.05
Additional Paid-In Capital	911.47	910.24	906.15	663.28	648.39	651.42
Retained Earnings	-254.79	-275.79	-239.73	-306.79	-181.72	-330.92
Treasury Stock	-118.54	-118.54	-98.26	-98.26	-47.28	-43.27
Comprehensive Income & Other	0.35	-1.18	-	-	-	-
Total Common Equity	538.58	514.83	568.27	258.28	419.43	277.27
Minority Interest	38.89	37.79	21.34	11.04	11.04	11.04
Shareholders' Equity	577.47	552.62	589.61	306.08	463.68	325.97
Total Liabilities & Equity	775.55	756.39	633.55	482.93	798.86	511.31
Total Debt	111.93	124.33	13.51	63.88	184.21	117.2
Net Cash (Debt)	263	209.44	426.4	322.26	523.26	334.13
Net Cash Growth	-26.43%	-50.88%	32.31%	-38.41%	56.61%	98.72%
Net Cash Per Share	2.70	2.11	4.61	7.59	5.31	5.82
Filing Date Shares Outstanding	96.44	96.09	99.9	58.57	46.47	49.28
Total Common Shares Outstanding	96.44	96.05	99.9	43.48	48.81	49.28
Working Capital	393.55	372.91	526.88	340.78	530.49	332.85
Book Value Per Share	5.58	5.36	5.69	5.94	8.59	5.63
Tangible Book Value	451.16	430.06	525.72	214.08	363.17	260.36
Tangible Book Value Per Share	4.68	4.48	5.26	4.92	7.44	5.28
Land	-	2.88	-	-	-	-
Buildings	-	9.08	1.02	-	-	-
Machinery	-	16.84	3.74	4.3	3.73	0.3
Leasehold Improvements	-	-	-	1.03	1.03	0.12

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q